Patients with psoriatic arthritis have higher levels of FeNO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement
- 1 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 39 (10), 2981-2988
- https://doi.org/10.1007/s10067-020-05050-2
Abstract
Background Psoriatic arthritis (PsA) patients are often affected by numerous comorbidities. However, contrasting results have been reported with regard to the respiratory involvement in PsA patients. The aim of this study was to evaluate the presence of subclinical airway inflammation in non-smoking PsA patients compared to patients with only psoriasis using the fraction of exhaled nitric oxide (FeNO) as an indirect marker of airway inflammation. Methods The study included 164 non-smoking psoriatic patients (Psoriasis Area of Severity Index or PASI score > 10): 82 with and 82 without PsA, who underwent FeNO tests at different flow rates (30, 50, 100, 200 mL/s). PsA patients were evaluated with Disease Activity in PSoriatic Arthritis Score (DAPSA). Both study groups were compared in terms of FeNO values and its association with the PASI score. The correlations between the variables were evaluated by means of Pearson's coefficient. Results Patient with PsA had higher levels of FeNO than those with psoriasis but without arthritis (at 30 mL/s, 71.09 +/- 18.40 ppb vs 66.88 +/- 19.12 ppb (NS); at 50 mL/s, 36.61 +/- 9.30 ppb vs 30.88 +/- 9.73 ppb (p < 0.001); at 100 mL/s, 19.09 +/- 4.66 ppb vs 16.63 +/- 4.90 ppb (p < 0.001); and at 200 mL/s, 10.88 +/- 2.53 ppb vs 9.43 +/- 2.55 ppb (p < 0.001), respectively). PASI score correlated to FeNO only in psoriatic patients without arthritis. However, CASPAR index correlated with FeNO (FeNO30: r = 0.81, p < 0.001; FeNO50: r = 0.84, p < 0.001; FeNO100: r = 0.71, p < 0.001; FeNO200: r = 0.58, p < 0.001). DAPSA was also correlated with FeNO to all flows (FeNO30: r = 0.43, p < 0.001; FeNO50: r = 0.33, p < 0.001; FeNO100: r = 0.34, p < 0.001; FeNO200: r = 0.25, p < 0.001). Conclusions PsA patients seem to have more commonly subclinical airway inflammation than those with only psoriasis. Further studies are needed to replicate these findings.This publication has 40 references indexed in Scilit:
- The association of sore throat and psoriasis might be explained by histologically distinctive tonsils and increased expression of skin-homing molecules by tonsil T cellsClinical and Experimental Immunology, 2013
- Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in TaiwanJournal of the European Academy of Dermatology and Venereology, 2011
- Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohortsClinical Rheumatology, 2011
- On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: structure and challengesJournal of the European Academy of Dermatology and Venereology, 2010
- Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severityThe Journal of Dermatology, 2010
- Arginase is overactive in psoriatic skinBritish Journal of Dermatology, 2010
- The burden of autoimmune disease: A comparison of prevalence ratios in patients with psoriatic arthritis and psoriasisJournal of the American Academy of Dermatology, 2009
- Interleukin-17A activation on bronchial epithelium and basophils: a novel inflammatory mechanismEuropean Respiratory Journal, 2009
- Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic diseaseJournal of the European Academy of Dermatology and Venereology, 2009
- Psoriasis and chronic obstructive pulmonary disease: a case-control studyBritish Journal of Dermatology, 2008